Nicardipine Hydrochloride (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Nicardipine Hydrochloride drug offered from Mylan Pharmaceuticals Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | nicardipine hydrochloride |
| SUBSTANCE NAME: | NICARDIPINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1996-07-19 |
| END MARKETING DATE: | 0000-00-00 |
Nicardipine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Nicardipine Hydrochloride from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/1) |
| START MARKETING DATE: | 1996-07-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-1020_4fa78e79-6bda-4fe6-ad6f-319afb539744 |
| PRODUCT NDC: | 0378-1020 |
| APPLICATION NUMBER: | ANDA074642 |
Other NICARDIPINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
